[1]
A. Setiawati, I. Darmansjah, and H. Mangunnegoro, “Safety and tolerability of moxifloxacin in the treatment of respiratory tract infections: a post-marketing surveillance conducted in Indonesia”, Med J Indones, vol. 14, no. 1, pp. 11-9, Feb. 2005.